Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

NCT: NCT06122610 · COMPLETED

NCT IDNCT06122610
StatusCOMPLETED
Start Date2025-03-07
Completion2026-05-31
SponsorUniversity of Wisconsin, Madison (OTHER)
First posted
Last updated

Brief Summary

The goal of this research is to determine if DetectnetTM PET/CT can be used to make Lutathera therapy safer for patients with neuroendocrine cancer. Participants will: * Complete two phases involving 6 visits * Undergo additional research PET/CT, and possibly SPECT/CT scans

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑